Richard Pulik - 28 Jun 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
CFO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik
Issuer symbol
ROIV
Transactions as of
28 Jun 2025
Transactions value $
-$18,828
Form type
4
Filing time
01 Jul 2025, 21:00:10 UTC
Previous filing
24 Jun 2025
Next filing
30 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pulik Richard CFO C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik 01 Jul 2025 0001885841

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Tax liability -$18,827 -1,653 -0.41% $11.39 399,472 28 Jun 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
F2 Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.